The Nuclear Medicine Liaison Group has been established by ANSTO, ANZSNM and AANMS as the key stakeholders within the nuclear medicine community in Australia to provide a platform for bi-directional communication between ANSTO and the nuclear medicine community who are users/consumers of ANSTO Health’s products.
The issues to be discussed are shown in the full Charter.
The initial members of the NMLG will be mutually agreed by ANSTO, ANZSNM and AANMS.
The NMLG shall consist of at least six elected members plus the CEO/President of each organisation ex officio. The quorum for a meeting shall be at least four members.